Navigation Links
Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs

American Association for Cancer Research Aims to Raise Awareness about the Importance of Clinical Trial Participation

PHILADELPHIA, Sept. 24 /PRNewswire/ --

News facts:

-- Most Americans with cancer would be receptive to participating in

clinical trials if they knew about them.

-- In a survey of 6,000 cancer patients, 85 percent were either unaware

or unsure that participation in a clinical trial was an option.

Seventy-five percent said they would have been willing to enroll had

they known it was possiblei.

-- This lack of knowledge is leading to a crisis in cancer drug

development with 80 percent of clinical trials in the U.S. being

delayed because of unfulfilled enrollmentii.

-- While clinical trials remain the only way to effectively test potential

new medications, fewer than 5 percent of adult cancer patients

participate in themiii. This lack of participation leads to delays in

clinical trials and slows patient access to new and possibly lifesaving

treatment options.

-- The American Association for Cancer Research (AACR), the proud

scientific partner of Stand Up to Cancer, a ground-breaking initiative

aimed at raising funds to accelerate cancer research and bringing new

therapies to patients more quickly, is committed to spreading knowledge

about cancer research and is on the front lines of the quest for

prevention and cure. AACR is taking a lead in raising awareness about

the urgent need to increase cancer clinical trial participation.

-- Clinical trials are not for everyone, but if you have been diagnosed

with any type of cancer, talk to your doctor about whether a clinical

trial may be right for you.

-- For information about AACR's progress toward the prevention and

cure of cancer, please visit

To view the Multimedia News Release, go to:

Commentary on clinical trials:

"The American Association for Cancer Research aims to educate the public about what a clinical trial can offer and ensure people know all of their treatment options, including clinical trials, at the time of their diagnosis. Through this process patients can make an educated decision when choosing their course of therapy with their doctor." - Raymond N. DuBois, M.D., Ph.D. President, AACR and Provost and Executive Vice President of Academic Affairs, M. D. Anderson Cancer Center

"The challenge is to make patients and healthcare providers more aware of clinical trials. While more funds for research are needed, progress also requires more participation in clinical trials." - Gwen Darien, Director of Survivor and Patient Advocacy, AACR

"Cancer patients need to ask their doctors about clinical trials. It's important to be proactive and find out about treatment options and decide which is right for you." - Connie Mielich, cancer survivor and clinical trial participant

"The care I received while participating in a clinical trial was the best I've ever had. The healthcare providers were very attentive to my needs. Some patients may have reservations about enrolling but I advise people to ask their doctor about clinical trials and discuss it with their loved ones." - Connie Mielich, cancer survivor and clinical trial participant

About the AACR

Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research and the prevention and cure of cancer. The membership includes more than 28,000 basic, translational, and clinical researchers, healthcare professionals' cancer survivors and advocates in the United States and 80 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs.

i Harris Interactive survey - data on file

ii CISCRP's 101 Facts About Clinical Research: Treatment & Cures of Disease." The Center for Information & Study on Clinical Research Participation. July 2007. df (16 Jan. 2008).

iii Lara P, et al. "Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment." The Journal of Clinical Oncology 19(2001):1728-1733.

SOURCE American Association for Cancer Research (AACR)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):